Status:
UNKNOWN
The Clinical Benefits of the Combination Use of Acupuncture and Antihistamine on Trigeminal Neuralgia
Lead Sponsor:
China Medical University Hospital
Conditions:
Trigeminal Neuralgia
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Trigeminal neuralgia is a paroxysmal extreme pain and is an unmet clinical need, we hope that our discovery about the antihistamine and acupuncture can be used in the treatment trigeminal neuralgia. T...
Detailed Description
Trigeminal neuralgia is a paroxysmal extreme pain that occurs in the region dominated by facial trigeminal nerve. It is characterized by repetition and irregularity. Once the disease occurs, the pain ...
Eligibility Criteria
Inclusion
- 1\. Age ≥ 20 2. Occurrence of episodes of intense facial paroxysmal pain in territory innervated by the trigeminal nerve (VAS score ≥ 6) 3. Presence of a normal neurologic examination 4. Neurologist confirm- Normal neuroimaging analysis 5. Duration of each pain episode \< 15 minutes
Exclusion
- 1\. Patient refuse to participate 2. Psychologic instability 3. Atypical pain location (eg, no specific trigger points) 4. Anticlotting therapy 5. Secondary trigeminal neuralgia
- Multiple sclerosis
- Temporomandibular joint disorders
- Neoplasias 6. Altered neurologic profile
- Hypoesthesia
- Dysesthesia
- Anesthesia
- Paresis 7. Association with other cranial nerve neuralgias (eg, glossopharyngeal neuralgia) 8. Imagiologic alterations 9. Proposed surgical intervention
- Compression of the Gasser ganglion
- Micro vascular decompression
- Radiofrequency rhizotomy
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04384224
Start Date
July 1 2020
End Date
February 28 2022
Last Update
September 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404